Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Understanding balance differences in individuals with multiple sclerosis with mild disability: an investigation of differences in sensory feedback on postural control during a Romberg task.
Evaluation of brainstem involvement in multiple sclerosis.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Synchrony analysis: application in early diagnosis, staging and prognosis of multiple sclerosis.
Lead Candidate (MIS416) Overview
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
EAE is not a useful model for demyelinating disease.
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Myeloradicular Form of Neuroschistosomiasis in a Six-Year-Old Boy Infected With Schistosoma mansoni.
Magnetization transfer from inhomogeneously broadened lines (ihMT): Improved imaging strategy for spinal cord applications.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Clinical use of brain volumetry.
Pages
« first
‹ previous
…
411
412
413
414
415
416
417
418
419
…
next ›
last »